Chemoinformaics analysis of Ethylenimine quinone
| Molecular Weight | 190.202 | nRot | 2 |
| Heavy Atom Molecular Weight | 180.122 | nRig | 44 |
| Exact Molecular Weight | 190.074 | nRing | 3 |
| Solubility: LogS | -8.208 | nHRing | 2 |
| Solubility: LogP | 6.802 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 27.1719 |
| nHD | 0 | BPOL | 15.1881 |
| QED | 0.223 |
| Synth | 6.024 |
| Natural Product Likeliness | 1.827 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.973 |
| HIA | 0.02 |
| CACO-2 | -5.688 |
| MDCK | 0.0000183 |
| BBB | 0.197 |
| PPB | 0.870259 |
| VDSS | 0.584 |
| FU | 0.0429527 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.13 |
| CYP2c19-sub | 0.949 |
| CYP2c9-inh | 0.086 |
| CYP2c9-sub | 0.765 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.102 |
| CYP3a4-sub | 0.95 |
| CL | 6.617 |
| T12 | 0.052 |
| hERG | 0.957 |
| Ames | 0.086 |
| ROA | 0.985 |
| SkinSen | 0.903 |
| Carcinogencity | 0.055 |
| EI | 0.004 |
| Respiratory | 0.521 |
| NR-Aromatase | 0.097 |
| Antiviral | No |
| Prediction | 0.873814 |